Carson Wealth (CWM LLC)’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.8M | Buy |
|
|||||
|
2025
Q2 | $3.3M | Buy |
|
|||||
|
2025
Q1 | $1.16M | Sell |
|
|||||
|
2024
Q4 | $2.99M | Buy |
|
|||||
|
2024
Q3 | $908K | Buy |
|
|||||
|
2024
Q2 | $943K | Buy |
|
|||||
|
2024
Q1 | $643K | Buy |
|
|||||
|
2023
Q4 | $382K | Buy |
|
|||||
|
2023
Q3 | $231K | Buy |
|
|||||
|
2023
Q2 | $131K | Buy |
|
|||||
|
2023
Q1 | $127K | Sell |
|
|||||
|
2022
Q4 | $155K | Buy |
|
|||||
|
2022
Q3 | $133K | Buy |
|
|||||
|
2022
Q2 | $98K | Buy |
|
|||||
|
2022
Q1 | $50K | Buy |
|
|||||
|
2021
Q4 | $18K | Buy |
|
|||||
|
2021
Q2 | $25K | Hold |
|
|||||
|
2021
Q1 | $25K | Hold |
|
|||||
|
2020
Q4 | $25K | Hold |
|
|||||
|
2020
Q3 | $25K | Hold |
|
|||||
|
2020
Q2 | $25K | Hold |
|
|||||
|
2020
Q1 | $25K | Hold |
|
|||||
|
2019
Q4 | $25K | Hold |
|
|||||
|
2019
Q3 | $25K | Hold |
|
|||||
|
2019
Q2 | $25K | Hold |
|
|||||
|
2019
Q1 | $25K | Buy |
|
|||||
|
2018
Q4 | $2K | Buy |
|